{"name":"ImmuneSensor Therapeutics Inc.","slug":"immunesensor-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IMSA101","genericName":"IMSA101","slug":"imsa101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"IMSA101","genericName":"IMSA101","slug":"imsa101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPbVJITFlhM1NKZzNlbjFsd1pUQkNkNTlyTTNJWHNXSFFHemEzcHRnbWIwYWd0Z08yQVY3cTdhaGhxMEFJVzJjdUpaMFA1OW01N1h3NmxiRHh2dkZMOGZfTnVqc1BLYmhydTA4Nks0RjUwcmoweFFvU3RNZmZrLVBtZlJ3QWZsaU5lR3NwZHFWbmltM3lpR1JsRV8yTlFZZDhCMTZWQnFQVmJDbHVvOWluZnB4al82XzlST3JZdkhKc2NrWmZseGF4T2lwU05mWk9kTmpLNmFLT05VdlZFZm9SZkRQSGRlemxBV0tKZktIRVg3c2YwN2xpWDEtTGR5aHlCZVVnRHBlZHdMY0lfWFhzanFOZm03c3hRNlQ4bG9SLWZNdVJxd2gwQVkxZDFFTERIMXJGNEpR?oc=5","date":"2026-02-12","type":"pipeline","source":"globenewswire.com","summary":"ImmuneSensor Therapeutics Doses First Patient with Aicardi - globenewswire.com","headline":"ImmuneSensor Therapeutics Doses First Patient with Aicardi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOOFhyUl94cTNEaGt0Z1g4Q1lLWWVPU2VtRjBFZ05fUDVuN3lJYmhuTlBXcTdKeXZlMUJLcnRabFVqMGxXYUliRXFNN25ZOF9vY1FLaXluZEY5a1BHd2puTEtIUXpUbkVsNXNoTVdPS1dHT01MNlNyQnZaVDNsRTVZV01ZM3NLRW5rS2ZpRWwzMEY0N3c?oc=5","date":"2024-11-22","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more - Medical Marketing and Media","headline":"Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPb0hZMUMyWUFrMkJpY0JBbVNsRF96V3lVUklfMHlBVzNRUERpdTJBYnZ3am90Uzhpbk9Zc281Q2xhWEJ2YTNBS2NTYkJBX2tnOUxIVmlLNTMxRUFRMFpRdkRDb0tfOHFGZlhFWWY3NGxPNGFuR201MUFFenpESFo4ZzJiemNqSFlkbE94V0RTVTY2dw?oc=5","date":"2024-09-17","type":"patent","source":"Yahoo Finance","summary":"ImmuneSensor Therapeutics Granted New U.S. Patent for its Oral cGAS Inhibitors - Yahoo Finance","headline":"ImmuneSensor Therapeutics Granted New U.S. Patent for its Oral cGAS Inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNS0xJRzdqU1hkaEV3c1BzZHd3V1BvUjFoLWo3aW80SktGMWdNaFBJYkViTE9YbkNxcy03WjNTTU1XbTlVMkdHWWdmeXJobFZIcnVVZ1BlcVJPX2VWenhyV2J4dFdodTBWcDZOTklYNDBvMXpURnZMQnhLa2d5WmcwWkRoTU53Nnd4aGFsY1c2MTU0SmZrUDhQeU14VkRMeXRNdW5nVU9Xal9Sd1JFZGRlMU5CMzNNTGlZSGJuUzhvWQ?oc=5","date":"2024-05-10","type":"trial","source":"The ASCO Post","summary":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer - The ASCO Post","headline":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNSVZKZUR0YU1YVzA4bTd4X0JKV08yS3NBejFEd01DMnNXMlg3QUNfSUV0VmlEZFBUb3lTX3JaeU5UdWZGMHI4a2VQUHJPc09IdlZCbFlYTW4ta1JfMmRqQm95aXhJeXM5d0hKYmdSN3lER0QybWtaUUEzTW03NXBJT1V4bWdHdS0ydGc?oc=5","date":"2024-05-03","type":"pipeline","source":"Dallas Innovates","summary":"ImmuneSensor Therapeutics Announces New President/CEO - Dallas Innovates","headline":"ImmuneSensor Therapeutics Announces New President/CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE01WFhab1Q1UlJISXd3akJKU2hqczJQSTVsNHBQMmtQWVpNSkQ3M3hybXFKa0UzSDBlbVJ5Vl84T0k3dVZISkloM2l2T09Da18zNW9xSHY5ZVlaZUktNE5vRV9kdWU2Mmc?oc=5","date":"2024-04-08","type":"pipeline","source":"Built In","summary":"13 Biotech Companies In Dallas To Know - Built In","headline":"13 Biotech Companies In Dallas To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNd0xfQ0dxa0VhdGNvZ1pjd21Td2ZuSS0zbjNqMWtDU1dmNU5CLV8xUkFsdVR5TjJFQTBrdVdudjg0WGN4QUJrdmNJYnZ2TEVTVnFFTXFxQU5STWdKc21XbkNMM0JuWXpqUTNFVklKcUpzTk4yV21DS2lPR1Yxd0dERWUtc1ExOTRfcF84MWI0MFNiLS1ZclZKM0FBS3dUbndRWU4wLUhHM2xndFRFcHVKak52cVUxWS1MM0NlUUQ5NkF2UEJKY1ZtMTRZbkkxenFYVGstVUw3TnNvUHlaQkNpMlAxeXZwdl8wdkFvQVBmbEV2ZXk5YlYzSkV6dkJ2bm9rb2lGWmVJcEw2czgyZEJscFB2cUdrdlRXcllUbnZVVVNxSUx0M0x6YlA0Z0ZNZ29VTVpXbE9Tdw?oc=5","date":"2024-01-08","type":"trial","source":"globenewswire.com","summary":"HDAC Inhibitor Clinical Trial Pipeline Appears Robust With - globenewswire.com","headline":"HDAC Inhibitor Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5wV3JlZlJNMlhqOHZqVFVVU1hOaVBscnVsVmo1UngzYmpSRUg3Nlk5VVNWeUdBY2llWWlRQVRkUWpmMkRvVFk5clFINUFMcmNfZHI4OV9RWm50S3pLZklvS3kycTEtdmpWaDUwX0lzRzE?oc=5","date":"2023-03-14","type":"regulatory","source":"pharmaphorum","summary":"Mersana stung by FDA hold on STING drug - pharmaphorum","headline":"Mersana stung by FDA hold on STING drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVkVsdEI3UUk2UEpaa1lNMkFIQ1Vvek52clFyNmttX2ZJenJLQTd6SHBmMWlBdGcyYzhHdUx0WkhpeEpoZWlCdlhVZXdLNnkwQnhNU0RiandSNjllUHcwZ1lJMHZkYkVjZm9TTXJJT0pNOTFBXzhxZVhISlBDQUxvSm1zdkVfck8wTXdianYteXJWbTRiTFEwMHBHRTNHQUtOWXpMcWlxRUJiSWp5VHFfWVdHbEkwX1U3?oc=5","date":"2022-09-19","type":"deal","source":"Fierce Pharma","summary":"RIGImmune subsumes Subintro in nasal drug delivery buyout, secures F-Prime investment - Fierce Pharma","headline":"RIGImmune subsumes Subintro in nasal drug delivery buyout, secures F-Prime investment","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}